Background
==========

Sarcoidosis is a chronic, systemic disease of unknown origin, characterized by the formation of noncaseating granulomas in affected organs, most commonly the lung. According to the ATS/ERS/WASOG \[[@B1]\] statement on sarcoidosis, the diagnosis is based on clinical and radiological findings and on histologic evidence. The technical availability of the fiberoptic bronchoscope has facilitated the development of the bronchoalveolar lavage procedure, which is useful for the collection of cells and secretions from the lower respiratory tract. Although this technique causes low risk to the patient, it is relatively invasive and inconvenient for the patients. Sputum induction has been proposed as a non-invasive method, useful to the investigation of asthma \[[@B3]\], and also of other interstitial lung disease (ILD) \[[@B4],[@B5]\], more specifically sarcoidosis \[[@B4],[@B6]-[@B9]\], pneumoconiosis due to dust exposure \[[@B10]\], Crohn\'s disease \[[@B11]\] and non-granulomatous ILD \[[@B4]\]. The exact role of induced sputum in the diagnosis and evaluation of disease activity in ILD and especially in sarcoidosis has not been clearly defined. Furthermore, no specific studies have been undertaken to evaluate the safety and functional effects of induced sputum in patients with ILD \[[@B5]\]. Today\'s attitude and opinion of researchers in this area is that induced sputum is a promising technique in assessing ILD, but its diagnostic role has not yet been clarified, and should be used as a complimentary tool to BAL for research and clinical monitoring \[[@B5],[@B12]\].

The pathogenesis of pulmonary sarcoidosis has been related to an increased production of Th1-like cytokines. However cytokine expression in sarcoidosis has not been systematically studied yet. It is well known that CD4^+^T cells can be divided in two subgroups on the basis of their cytokines profile. Th1 cells produce type 1 cytokines {IL-2, tumor necrosis factor-(TNF)-α, interferon gamma-(IFN-γ)}, while Th2 cells produce type 2 cytokines (IL-4, IL-5, IL-6, IL-10, IL13).

As far as we know there are only a few studies regarding the Th1/Th2 balance in sarcoidosis and all of them either in bronchoalveolar lavage fluid (BALF) or in blood \[[@B13]-[@B15]\]. Therefore, the aim of this study was to explore induced sputum (IS) CD4^+^Th1 T-lymphocyte subpopulation and to compare them with those in the BALF in patients with sarcoidosis.

Methods
=======

Subjects
--------

The demographic and clinical characteristics of the patients and controls are shown in Table [1](#T1){ref-type="table"}. Twenty-one consecutive sarcoidosis patients, 9 male and 12 female, of median (range) age 46 (25--65) years who were investigated in the sarcoidosis clinic of our Hospital were enrolled in the study. Three of them were smokers and 18 non-smokers. The ATS/ERS/WASOG statement \[[@B1]\] on sarcoidosis was followed for the diagnosis, based on history, clinical symptoms, standard chest radiography, computed tomography, lung Ga^67^scintigraphy and laboratory tests (serum angiotensin-converting enzyme). All of them had transbronchial or open lung biopsy with histopathological evidence of noncaseating epithelioid cell granulomas.

###### 

Demographic and spirometric characteristics of sarcoidosis patients and control subjects. Values are expressed as mean ± SD, and age as median (range).

  **Characteristics**      **Sarcoidosis**      **Normal subjects**
  ------------------------ -------------------- ---------------------
  Number                   21                   10
  Sex: Male/Female         12/9                 5/5
  Age, yr                  46 (25--65)          39 (26--60).
  Smokers/non smokers      18/3                 0/10
  FVC, % pred              93.1 ± 6.4           103 ± 13.7
  FEV~1~, % pred           92.3 ± 6.6           101.1 ± 19
  FEV~1~/ FVC, % pred      95.3 ± 5.9           100.3 ± 8.6
  K CO % pred              82.3 ± 8.1           96 ± 6.3
  Radiographic Stage (n)   I: 8, II: 7,III: 6   

Abbreviations: KCO = Carbon monoxide transfer coefficient, FVC % pred : Forced vital capacity % predicted, FEV1 % pred : Forced expiratory volume within the first second % predicted

According to chest radiography classification of sarcoidosis, 8 had type I disease (lymphadenopathy alone, 7 type II disease (lymphadenopathy and parenchymal opacities), and 6 type III disease (only parenchymal opacities).

The control group included 10 healthy nonsmoker volunteers (5 female, 5 male), median (range) age 39 (26 -- 60) years who were able to produce adequate sputum samples following sputum induction. Patients and controls with acute respiratory infection during the 6 weeks prior to the study were excluded. The Ethics committee of our hospital approved the protocol and all patients and controls gave their consent.

Spirometry
----------

Spirometry was performed with a computerized system (MasterLab, Jaeger2.12, Germany). The measurement was performed using standard protocols according to ATS guidelines \[[@B16]\].

Sputum induction
----------------

Sputum was induced by the inhalation of hypertonic saline aerosol solution, generated by an ultrasonic nebulizer (Ultraneb 2000, DeVilbiss, Somerset, PA, USA), as previously described \[[@B6],[@B17],[@B18]\].

Sputum processing
-----------------

Sputum was processed within 1 hour after termination of the induction. The method of sputum examination described earlier \[[@B17],[@B18]\] was used with some modifications \[[@B6]\].

Bronchoalveolar lavage
----------------------

Fiberoptic bronchoscopy with BAL was performed within two weeks from the IS, as part of routine clinical management, according to recommended guidelines and previous reports \[[@B6],[@B20]\].

BALF processing
---------------

The recovered BAL fluid was filtered through sterile gauze (Thompson, Ontario, Canada) and centrifuged at 400 g for 15 minutes at 4°C. Total cell counts were determined using an improved Neubauer counting chamber, and expressed as the total number of cells per mL of aspirated fluid. The pellet was washed three times with cold PBS-Dulbecco\'s and the cells were adjusted to a final concentration of 10^6^cells/mL with RPMI1640 plus 2%FCS. The slide preparation was performed as previously reported \[[@B6]\].

Immunocytochemical analysis
---------------------------

The immunocytochemical analysis and T-cell determination were performed in sputum cytospins. Briefly, sputum lymphocytes were stimulated by incubating suspension B in 24-well plates at a concentration of 2 × 10^3^cells/μL for 5 h, under 5% CO~2~, at 37°C, in RPMI-1640 at 10% FCS in the presence of phorbol 12-myristate 13 acetate (PMA) 25 ng/mL, ionomycin 1 μmoL and Brefeldin A 10 μg/Ml (Sigma-AldrichCorp. St.Louis, MO, USA). Cytospins were made using cytocentrifugation of 50 μL of the stimulated suspension and were stored at -80°C for immunocytochemical analysis later. Approximately 175,000 cells were cytospined on each slide (3500 cells/μl × 50 μl = 175,000 cells), among which there was a sufficient number of lymphocytes to stain.

After defrosting the slides, they were fixed in acetone for 10 min and rehydrated in Tris-Buffered Saline (TBS). The double immunocytochemical method was performed in two steps as previously described \[[@B21]\]. Briefly, the specimens were first incubated for 30 min with bovine serum to block the unspecific binding and then were exposed to the first primary antibody at a dilution of 1:50 for 30 min at room temperature. After washing inTBS three times they were exposed to the first secondary antibody, rabbit anti mouse immunoglobulin fluorescein isothiocyanate (FITC)-conjugated for 15 min (ImmunotechMarseille, France) at a dilution of 1:50. After washing in TBS three times they were exposed to the secondary primary antibody at a dilution of 1:50 for 30 min at room temperature. After washing in TBS three times they were exposed to the second secondary antibody, rabbit anti-mouse immunoglobulin phycoerythrin-conjugated (IgG-PE) for 15 min (Immunotech Marseille, France) at a dilution of 1:50. After washing in TBS three times the slides were mounted with 30% glycerol in TBS. Two investigators examined the slides under ultraviolet microscope and their results were averaged. Three replicate measurements were performed by each observer in 10 slides. Both intra- and inter- observer coefficient of variation were \<15%. The ratio of CD4^+^-IFN-γ positive cells to CD4^+^-IL4 positive cells was calculated. For the estimation of each ratio, 500 T-cells were counted with more than one cytospin stained if necessary, because this number was sufficient to obtain a mean value per subject that remained constant after further increasing the number of cells counted. Results were also expressed as percentage of lymphocytes by dividing the number of lymphocytes stained per slide by total the number of lymphocytes per slide. Negative controls were obtained by the use of mouse-anti-mouse immunoglobulin to estimate the non specific binding. Positive controls were obtained by the use of T-lymphoma cells cytospined on slides. Macrophages were excluded from counting by morphology.

Measurement of CD4^+^-IFN-γ and CD4^+^-IL4 producing T-cells
------------------------------------------------------------

The primary anti CD4 mouse anti-human monoclonal antibody with secondary rabbit anti-mouse IgG- FITC antibody and the primary anti-IFN-γ mouse antihuman monoclonal antibody (Caltag Burlingame, CA, USA) with secondary rabbit antimouse IgG-phycoerythrin-conjugated (IgG-PE) antibody were used. At least 500 CD4^+^cells were counted to estimate the number of CD4^+^-IFN-γ cells. Also the same method was applied for staining CD4^+^-IL-4 producing cells with anti-IL4 antibody (Caltag Burlingame, CA, USA).

Statistics
----------

All analyses were performed using the statistical software StatsDirect for Windows version2.4.1 (Camcode; Cambridge, UK). Results are expressed as mean ± SD, or median (range), unless otherwise indicated. The *Shapiro-Wilk W*test for normality was applied to assess normality. Differences between sarcoidosis patients and controls were tested usingt-test for normally and the Mann-Whitney U test for non normally distributed data. Differences between the BALF and sputumwithingroupswere tested using the paired student\'s t-test for normally and theWilcoxon\'s signed rank test for non-normally distributed variables. Correlation between cell numbers and T lymphocyte subsets were analyzed using the Pearson\'s correlation coefficient. A p value of \<0.05 was considered as statistically significant

Results
=======

Patients with sarcoidosis were older than normal control subjects and had lower FVC, and FEV~1~values but the differences were not statistically significant. Induced sputum and BALF were tolerated well by all subjects, without any adverse events (Table [1](#T1){ref-type="table"}).

In BALF the percentage of IFN-γ producing CD4+ Tcells was significantly higher in patients with sarcoidosis than in normal control subjects (mean ± SD, 53.1 ± 17.9 versus 38.1 ± + 7.7, p = 0.019) after the stimulation with PMA/ionomycin. In induced sputum the percentage of IFN-γ producing CD4+ T cells was significantly higher in patients with sarcoidosis than in normal control subjects (mean ± SD, 60.0 ± 23.3 versus 35.60 ± 12.46, p = 0.003) after the stimulation. No significant differences were detected between sarcoidosis patients and control subjects regarding the proportion of IL-4 producing CD4+ T cells in BALF (p = 0.46) as well as in induced sputum (p = 0.055) (Table [2](#T2){ref-type="table"}). The ratio Th1/Th2 was found significantly higher in BALF (p = 0.007) and also in induced sputum compared with healthy controls.

###### 

Mean ± SD of Th1, Th2 lymphocyte subsets in induced sputum (IS) and bronchoalveolar lavage fluid (BALF) in sarcoidosis patients and control subjects.

  Induced sputum         BALF                                     
  ---------------------- ------------- ------------ ------------- ------------
                         Th1           Th2          Th1           Th2
                                                                  
  Control                35.6 ± 12.4   0.2 ± 0.15   38.1 ± 7.7    0.3 ± 0.14
  Sarcoidosis patients   60.0 ± 23.3   0.2 ± 0.12   53.1 ± 17.9   0.2 ± 0.11
  *P*                    0.003         0.46         0.019         0.55

\* Paired t-test or Wilcoxon\'s signed rank test, unadjusted p-values.

No statistically significant difference was found between induced sputum and BALF within groups (paired t test). A significant correlation was found between BALF and IS in the percentage of IFN-γ producing CD4+ T cells counts (r= 0. 685, p = 0.006) (Figure [1](#F1){ref-type="fig"}).

![Correlation of CD4+ IFN-γ cells between bronchoalveolar lavage fluid (BALF) and induced sputum (IS).](1471-2466-5-8-1){#F1}

Discussion
==========

To the best of our knowledge this is the first study in the literature to investigate the balance Th1/Th2 in sarcoidosis with the method of induced sputum. The main finding of this study is that a Th1-like cytokine pattern can be observed in CD4+ BALF as well as induced sputum T lymphocytes. We also detected a positive correlation between CD4+ IFN-γ producing T cells in induced sputum and those in BALF in sarcoidosis patients (p = 0.0006, r = 0.685).

We have previously shown that inflammation in sarcoidosis could be effectively and non-invasively determined by the analysis of cell differential counts and T-lymphocyte subsets in induced sputum \[[@B6]\]. We demonstrated that induced sputum can discriminate between patients with sarcoidosis and normal subsets on the basis of the profile of airway inflammatory cells, including lymphocytes \[[@B6]\]. Based on our findings that there is a positive correlation between BALF and induced sputum lymphocyte counts (r = 0.616) and CD4+/CD8+ ratio (r = 0.7) we aimed to evaluate the Th1/Th2 balance in sarcoidosis in both BALF and induced sputum. As it has already been reported, the mean CD4+/CD8+ ratio was not significantly different between BALF and induced sputum in 20 sarcoidosis patients (p \> 0.253) and in normal controls (p \> 0.3). In our study population a CD4+/CD8+ ratio ≥ 2.5 was found on 17 patients in induced sputum, while a CD4+/CD8+ ratio \> 4 was found in 12 (60%) patients \[[@B6]\].

The balance between Th1 and Th2 helper cells and their associated cytokine patterns can in an immune response influence the phenotype and progression of several clinical diseases. An imbalance in the expression of Th1 and Th2 type cytokines by alveolar cells is thought to play an important role in the immunopathogenesis of sarcoidosis \[[@B22]-[@B26]\]. Previous authors have shown a spontaneous release from alveolar cells of the Th1 type cytokines IFN-γ and IL-2 but not Th2 type cytokines \[[@B24],[@B26]-[@B29]\]. Additionally, there are no data on cytokine profiles in the late stages of fibrotic sarcoidosis to assess the contribution of Th1 or Th2 cytokines to the fibrotic process. Experimental models confirm that Th2-mediated granulomatous responses are more fibrotic than Th1-mediated inflammation, so in the absence of human data, there is uncertainty as to the relevant immune processes in fibrotic pulmonary sarcoidosis. Conceivably, patients with fibrotic sarcoidosis are those who switch to a more fibrotic Th2 response later in the course of the disease, or have a persistent dominant Th2 response from the iniatial stages of disease \[[@B29],[@B30]\]. Furthermore, data support the immunopathogenetic concept of compartmentalization and the predominance of CD4+ T cells producing mainly Th1 type cytokines in acute pulmonary sarcoidosis, which becomes less prominent during the course of the disease \[[@B15]\]. However, in a study using T cell clones from BALF, Baumer et al. found equal levels of Th1 and Th2 cytokine gene expression in patients with sarcoidosis \[[@B31]\]. Thus, the purpose of the present study was to further investigate the phenotype of T lymphocytes in BALF and in induced sputum in patients with pulmonary sarcoidosis with focus on expression of markers indicating Th1 and Th2 cellular function. Our findings suggest a shift toward a type-1 phenotype in CD4+ T-cell populations in accordance with previous studies in BALF and in peripheral blood \[[@B13]-[@B15],[@B32],[@B33]\]. Intracellular cytokine staining could be useful to study cytokine expression in sarcoidosis \[[@B6],[@B14]\]. These data are in agreement with those investigating the cytokine profile of T cell subsets with other methods like flow cytometry \[[@B13],[@B32],[@B33]\]. Inui et al. \[[@B13]\] investigated the alteration of the Th1/Th2 and Tc1/ Tc2 balance in sarcoidosis, using cytokine flow cytometry. The authors showed for the first time a significantly higher percentage of IFN-γ producing CD4+ T cells together with a markedly increased ratio of IFN-γ/IL-4-producing CD4+ T cells in BALF, after PMA/ ionomycin stimulation in patients with sarcoidosis compared with normal subjects. On the other hand, there were no differences in the percentages of IFN-γ or IL-4- producing CD8+ T cells in either the peripheral blood or BALF between patients and controls. In addition, a recent report in eighteen patients with untreated sarcoidoisis, examined the expression of Th1 associated chemokine and cytokine receptors CXCR3, CCR5, and interleukin IL-12R, IL-18R, respectively, as well as of the Th2 associated chemokines receptors CCR4 and CXCR4 on CD4+ and CD8+ T cells \[[@B33]\]. That report showed the lung accumulation of the above Th1 associated receptors, in agreement with recent data of our group \[[@B34],[@B35]\].

Conclusion
==========

This report is the first to evaluate the critical balance of Th1 to Th2 cells with the method of Induced sputum. In conclusion, these data demonstrate that there are increased numbers of CD4+ IFN-γ producing T cells in induced sputum from patients with pulmonary sarcoidosis, in accordance with the shift towards the Th1 response known to exist in BALF and peripheral blood. The positive correlation between the CD4+ IFN-γ producing T cells in BALF and in induced sputum, suggest that sarcoidosis patients could be followed up with this noninvasive method which has to be investigated in further studies.
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